OSTEOPATHIC BOARD CERTIFICATION

The Clinical Practice Pathway closes in 2026. The application for the 2026 exam opens May 1, 2026.

Addiction Medicine 2025 Longitudinal Assessment References

Due to copyright restrictions, the Addiction Medicine Conjoint Committee cannot provide most reference materials used for longitudinal assessment. However, a list of references used for the 2025 longitudinal assessment can be found below.

  • Addiction (Mar 2008); Vol. 103, Issue 3; Exposure to opioid maintenance treatment reduces long-term mortality; pg. 462-468; The Cochrane Database of Systematic Reviews (2003); Vol. 3; Methadone maintenance at different dosages for opioid dependence
  • The New England Journal of Medicine (Nov 2000); Vol. 343, Issue 18; A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence; pg. 1290-1297
  • Critical Care Medicine (Jul 2024); Vol. 52, Issue 7; Variation in use of medications for opioid use disorder in critically ill patients across the United States; pg. e365-e375
  • Irish Journal of Medical Science (Mar 2024); Effect of oral naloxone on opioid-induced constipation in methadone maintenance treatment patients, a double-blind, placebo-control, clinical trial
  • American Journal of Preventive Medicine (May 2020); Vol. 58, Issue 5; Trends in the prevalence of current, daily, and nondaily cigarette smoking and quit ratios by depression status in the U.S.: 2005-2017; pg. 691-698; Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco (Jan 2021); Vol. 23, Issue 2; Longitudinal association between smoking abstinence and depression severity in those with baseline current, past, and no history of major depressive episode in an international online tobacco cessation study; pg. 267-275
  • American Society of Addiction Medicine (Updated 2023); About the ASAM Criteria.
    https://www.asam.org/asam-criteria/about-the-asam-criteria
  • American Society of Addiction Medicine (Updated 2024); The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder; pg. 69.
    https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/stud_guideline_document_final.pdf?sfvrsn=71094b38_1
  • Canadian Family Physician (Feb 2020); Vol. 66, Issue 2; Cannabis use during pregnancy and postpartum; pg. 98-103.
  • Annals of Medicine (Nov 2021); Vol. 53, Issue 1; Drug dependence is not addiction—and it matters; pg. 1989-1992.
  • Current Medicinal Chemistry (2015); Vol. 22, Issue 6; Alcohol addiction: a molecular biology perspective; pg. 670-684
  • Neuropharmacology (Aug 2017); Vol. 122; Genetics and genomics of alcohol responses in Drosophila; pg. 22-35
  • The American Journal of Drug and Alcohol Abuse (Nov 2014); Vol. 40, Issue 6; Molecular neurobiology of addiction: what’s all the (Δ)FosB about?; pg. 428-437
  • Proceeding of the National Academy of Sciences of the United States of America (Sep 2001); Vol. 98, Issue 20
  • DeltaFosB: a sustained molecular switch for addiction
  • Journal of Neural Transmission (Feb 2024); Vol. 131, Issue 5; It is not just about transcription: involvement of brain RNA splicing in substance use disorders; pg. 495-503.
  • Drug and Alcohol Dependence (Sep 2020); Vol. 214; Cocaine use and overdose mortality in the United States: evidence from two national data sources, 2002-2018
  • InformedHealth.org (Updated Jun 2022); In brief: Cognitive behavioral therapy (CBT).
    https://www.ncbi.nlm.nih.gov/books/NBK279297
  • JAMA Psychiatry (Dec 2020); Vol. 77, Issue 12; Efficacy of a psychosocial pain management intervention for men and women with substance use disorders and chronic pain: a randomized clinical trial; pg. 1225-1234; Journal of Addictive Diseases (Jun 2023); Co-occurring pain and addiction: prognostic implications for healthcare professionals in residential treatment for substance use disorder; pg. 1-10
  • SAMHSA (Updated Oct 2023); Substance use confidentiality regulations.
    https://www.samhsa.gov/about-us/who-we-are/laws-regulations/confidentiality-regulations-faqs
  • StatPearls (Updated Jan 2024); Opioid use disorder.
    https://www.ncbi.nlm.nih.gov/books/NBK553166/
  • StatPearls (Updated Nov 2022); Patient rights and ethics.
    https://www.ncbi.nlm.nih.gov/books/NBK538279/
  • The ASAM Essentials of Addiction Medicine, 3rd ed. (2020); pg. 24.
  • The ASAM Principles of Addiction Medicine, 6th ed. (2018); Ch. 49: Physician Health Programs and Addiction Among Physicians